?
Your prediction
China Medical System Holdings Ltd Stock
Pros and Cons of China Medical System Holdings Ltd in the next few years
Pros
Cons
Performance of China Medical System Holdings Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| China Medical System Holdings Ltd | 1.860% | 0.625% | 9.524% | 61.809% | 15.000% | 15.000% | 22.901% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 0.970% | 0.980% | 1.980% | -3.738% | 5.102% | -23.134% | -6.364% |
| Tianjin Zhon.xin Ph.s Yc1 | 1.190% | 7.186% | 11.755% | 51.491% | 4.703% | 154.497% | 338.841% |
| Livzon Pharmaceutical Group Inc | 0.660% | 0.662% | -1.935% | -0.654% | -3.185% | -3.797% | -5.590% |
News
DTE’s Stargate Deal Turns Power Into Profits
The financial landscape of early 2026 has been defined by a singular, violent theme: rotation. As investors flee the speculative froth of the technology sector, capital is finding a new home in
New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On
Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the
New Medicare Advantage Rule Forbids Coverage of Procedures Used by Over 4 Million Seniors
Medicare Advantage plans are an alternative to traditional Medicare that can provide coverage for more services. The Bipartisan Budget Act of 2018 allowed Advantage Plans to cover things that were


